IFED and LABU offer distinct approaches to equity market exposure. IFED provides rules-based large-cap selection influenced by Federal Reserve policy signals, while LABU seeks amplified daily returns from the biotechnology sector. These ETFs do not compete directly but serve as alternative strategies for investors pursuing different risk-return profiles within U.S. equities. The comparison highlights structural variances in indexing, leverage, costs, and thematic focus relevant to current monetary and sector environments.
IFED is an ETN issued by UBS that tracks the IFED Large-Cap US Equity Index Total Return. The index employs a proprietary methodology to classify the monetary environment as expansive, restrictive, or indeterminate and selects approximately 75 large-cap U.S. stocks based on firm-specific metrics favoring performance under prevailing Federal Reserve conditions. Top holdings typically include names such as Citigroup, Dell Technologies, and Valero Energy, with sector allocations shifting dynamically among cyclicals, defensives, and rate-sensitive areas. The expense ratio is 0.45%. As an ETN, the product carries issuer credit risk and does not hold underlying securities. Rebalancing occurs when the monetary classification changes, emphasizing a passive yet adaptive strategy.
LABU is a leveraged ETF from Direxion that seeks daily investment results, before fees and expenses, equal to 300% of the daily performance of the S&P Biotechnology Select Industry Index. The fund holds a basket of biotechnology stocks and uses swaps and other derivatives to achieve the 3x leverage target. Holdings number in the hundreds, with significant weight in names such as Moderna, Natera, and AbbVie. The expense ratio is approximately 0.95%. Daily reset mechanics and leverage amplify both gains and losses, resulting in high volatility suited to short-term trading rather than long-term holding. The structure remains fully invested in the target sector with no active stock selection beyond index replication.
Monetary policy remains a central driver for both ETFs. Changes in Federal Reserve interest rate expectations influence capital allocation across equities, affecting IFED’s dynamic sector tilts and broader market sentiment for LABU’s biotechnology holdings. Biotech faces additional catalysts including clinical trial outcomes, regulatory approvals, and funding availability, which can accelerate or constrain sector rotation. Macro factors such as inflation trends, economic growth signals, and healthcare policy developments create overlapping influences. Risks include policy missteps for IFED and clinical or reimbursement setbacks for LABU, underscoring the importance of diversification and risk management in current cycles.
In recent market cycles, IFED has exhibited moderate volatility consistent with its large-cap, policy-adjusted approach, with performance tied to shifts in Federal Reserve signals and sector rotations. LABU has demonstrated substantially higher volatility due to 3x daily leverage, amplifying biotechnology sector movements driven by earnings, mergers, and innovation news. Relative positioning shows IFED offering more stable exposure across economic regimes, while LABU provides magnified participation in biotech rallies or declines. Investors evaluating fund performance should consider these structural differences rather than isolated returns, as leverage and reset features in LABU can lead to compounding effects over extended periods.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to uncover additional opportunities aligned with your investment criteria.
Tickeron’s AI would currently assign higher favorability to IFED based on its lower expense ratio, diversified large-cap profile, and rules-based adaptation to monetary conditions, which support more consistent positioning across market regimes. LABU’s leveraged structure introduces elevated risk and daily reset dynamics that may suit tactical applications but increase structural complexity. The assessment rests on observable factors including cost efficiency, diversification, and alignment with broader sector momentum rather than short-term price action.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day RSI Indicator for IFED moved out of overbought territory on November 12, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 48 instances where the indicator moved out of the overbought zone. In 36 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a move down at 75%.
The Moving Average Convergence Divergence Histogram (MACD) for IFED turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 34 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
IFED moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IFED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
IFED broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IFED entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on November 18, 2026. You may want to consider a long position or call options on IFED as a result. In 73 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The 10-day moving average for IFED crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where IFED advanced for three days, in 180 of 221 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
LABU saw its Momentum Indicator move below the 0 level on November 10, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned negative. In 90 of the 94 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for LABU turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 49 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
LABU moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LABU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for LABU entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +17.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where LABU advanced for three days, in 293 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
LABU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
| IFED | LABU | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | N/A |
| Stochastic ODDS (%) | 1 day ago 83% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 83% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 68% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 72% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 72% | 1 day ago 90% |
| Advances ODDS (%) | 10 days ago 81% | 10 days ago 90% |
| Declines ODDS (%) | 2 days ago 70% | 1 day ago 90% |
| BollingerBands ODDS (%) | 1 day ago 73% | 1 day ago 89% |
| Aroon ODDS (%) | 1 day ago 65% | 1 day ago 90% |
A.I.dvisor indicates that over the last year, LABU has been loosely correlated with RCUS. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if LABU jumps, then RCUS could also see price increases.
| Ticker / NAME | Correlation To LABU | 1D Price Change % | ||
|---|---|---|---|---|
| LABU | 100% | -0.49% | ||
| RCUS - LABU | 60% Loosely correlated | -3.84% | ||
| LYEL - LABU | 57% Loosely correlated | +1.61% | ||
| LGND - LABU | 56% Loosely correlated | +1.67% | ||
| BHVN - LABU | 54% Loosely correlated | -2.57% | ||
| CUE - LABU | 48% Loosely correlated | +68.20% | ||
More | ||||